Skip to main content
. 2005 Feb;139(2):306–313. doi: 10.1111/j.1365-2249.2004.02690.x

Table 1.

MBL genotype frequencies (%) in CF patients and healthy controls.

CF n = 112 Controls n = 200
MBL-sufficient genotypes A/A HYA/HYA 10·7  6·5
HYA/LXA 10·7 13·5
HYA/LYA 10·7 15·5
LYA/LYA  4·5  3·5
LYA/LXA 12·5 13·5
LXA/LXA  8·9  5·5
YA/0 HYA/LYB  9·8 10·0
HYA/LYC  0·0  0·5
HYA/HYD  6·3  7·5
LYA/LYB  4·5  6·0
LYA/LYC  0·9  0·0
LYA/HYD  2·7  4·0
MBL-deficient genotypes XA/0 LXA/LYB  4·5  5·0
LXA/HYD  8·0  1·5
LXA/LYC  0·0  0·5
0/0 LYB/LYB  1·8  3·0
LYB/LYC  0·9  0·0
LYB/HYD  0·9  1·0
LYC/HYD  0·9  1·0
HYD/HYD  0·9  2·0